carbamazepine has been researched along with Weight Reduction in 7 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The interaction between clearance of phenytoin, valproic acid, phenobarbital and carbamazepine, and changes in body weight was determined in a 19-year-old obese woman with epilepsy (body weight 93 kg, BMI 36." | 7.69 | Clearance of phenytoin and valproic acid is affected by a small body weight reduction in an epileptic obese patient: a case study. ( Ashikari, Y; Chiba, S; Kodama, Y; Kuranari, M; Sakata, T; Takeyama, M, 1996) |
| "Single-dose (200 mg) carbamazepine pharmacokinetics was evaluated in six obese, otherwise healthy subjects, before and after a mean +/- SEM weight reduction of 30." | 7.68 | Significant weight reduction in obese subjects enhances carbamazepine elimination. ( Berry, EM; Caraco, Y; Levy, M; Zylber-Katz, E, 1992) |
| " But seizures occurred and the treatment by carbamazepine induced decreased blood level of itraconazole." | 3.74 | [Miliary cerebral Histoplasma capsulatum in an HIV-negative patient]. ( Bellard, S; Blanchard, C; Granier, H; Nicolas, X; Talarmin, F; Zagnoli, F, 2007) |
| "The interaction between clearance of phenytoin, valproic acid, phenobarbital and carbamazepine, and changes in body weight was determined in a 19-year-old obese woman with epilepsy (body weight 93 kg, BMI 36." | 3.69 | Clearance of phenytoin and valproic acid is affected by a small body weight reduction in an epileptic obese patient: a case study. ( Ashikari, Y; Chiba, S; Kodama, Y; Kuranari, M; Sakata, T; Takeyama, M, 1996) |
| "Single-dose (200 mg) carbamazepine pharmacokinetics was evaluated in six obese, otherwise healthy subjects, before and after a mean +/- SEM weight reduction of 30." | 3.68 | Significant weight reduction in obese subjects enhances carbamazepine elimination. ( Berry, EM; Caraco, Y; Levy, M; Zylber-Katz, E, 1992) |
| "To explore the time course of treatment-emergent adverse events (AEs) during topiramate (TPM) adjunctive therapy." | 1.33 | Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine. ( Majkowski, J; Neto, W; Van Oene, J; Wapenaar, R, 2005) |
| "Glossopharyngeal neuralgia is a rare disease." | 1.30 | Glossopharyngeal neuralgia: a study of 6 cases. ( Baykal, S; Ceylan, S; Duru, S; Karakuş, A; Koca, O, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weaver, D | 1 |
| Chorny, V | 1 |
| Tewari, S | 1 |
| Janszky, J | 1 |
| Horvath, R | 1 |
| Komoly, S | 1 |
| Majkowski, J | 1 |
| Neto, W | 1 |
| Wapenaar, R | 1 |
| Van Oene, J | 1 |
| Blanchard, C | 1 |
| Nicolas, X | 1 |
| Zagnoli, F | 1 |
| Granier, H | 1 |
| Talarmin, F | 1 |
| Bellard, S | 1 |
| Kuranari, M | 1 |
| Chiba, S | 1 |
| Ashikari, Y | 1 |
| Kodama, Y | 1 |
| Sakata, T | 1 |
| Takeyama, M | 1 |
| Ceylan, S | 1 |
| Karakuş, A | 1 |
| Duru, S | 1 |
| Baykal, S | 1 |
| Koca, O | 1 |
| Caraco, Y | 1 |
| Zylber-Katz, E | 1 |
| Berry, EM | 1 |
| Levy, M | 1 |
1 review available for carbamazepine and Weight Reduction
| Article | Year |
|---|---|
[ZONISAMIDE: FIRST CHOICE AMONG THE FIRST-LINE ANTIEPILEPTIC DRUGS IN FOCAL EPILEPSY].
Topics: Adolescent; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Drug Administratio | 2015 |
6 other studies available for carbamazepine and Weight Reduction
| Article | Year |
|---|---|
Case 1: Joint Pain, Weight Loss, Fatigue, and Persistent Pleural Effusions in 17-year-old Boy.
Topics: Adolescent; Anticonvulsants; Arthralgia; Asthma; Carbamazepine; Diabetes Mellitus, Type 2; Diagnosis | 2015 |
Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Anxiety; Carbamazepine; Double-Blind Method; Drug Therapy, | 2005 |
[Miliary cerebral Histoplasma capsulatum in an HIV-negative patient].
Topics: Anticonvulsants; Antifungal Agents; Brain; Carbamazepine; Drug Interactions; Hepatomegaly; Histoplas | 2007 |
Clearance of phenytoin and valproic acid is affected by a small body weight reduction in an epileptic obese patient: a case study.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Half-Life; Humans; Metabolic Clearance Rate | 1996 |
Glossopharyngeal neuralgia: a study of 6 cases.
Topics: Adult; Analgesics, Non-Narcotic; Bradycardia; Carbamazepine; Cranial Nerve Diseases; Female; Glossop | 1997 |
Significant weight reduction in obese subjects enhances carbamazepine elimination.
Topics: Administration, Oral; Adult; Body Mass Index; Carbamazepine; Diet, Reducing; Female; Half-Life; Huma | 1992 |